Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Australia
Clinical trial register · Australia

Clinical Trials in Australia

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3378 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:19 UTC
3378
Studies in scope
all four open statuses
1824
Recruiting now
open to new participants
781
Lead sponsors
across recruiting studies
Top sites
Melbourne 29 Clayton 18 Darlinghurst 15 Adelaide 13 Parkville 11

Trials in this register

89 of 3378 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Novartis Pharmaceuticals
Phase 2
259
Sydney, Waitara, Melbourne
2026-09-29
Recruiting
Novartis Pharmaceuticals
Phase 2
180
Adelaide, Frankston, Melbourne, Mulgrave
2026-09-18
Recruiting
A Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors
NCT07801508Advanced Gastroesophageal Adenocarcinoma, Advanced Breast Cancer, Triple-negative Breast Cancer, Advanced Non-small Cell Lung Cancer
Novartis Pharmaceuticals
Phase 1
66
Darlinghurst
2026-09-08
Recruiting
Novartis Pharmaceuticals
Phase 2
344
Southport, Nedlands
2026-08-24
Recruiting
Novartis Pharmaceuticals
Phase 3
710
Sydney, Melbourne, Parkville
2026-07-10
Recruiting
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
NCT07387926Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Phase 1/2
50
Sydney, Brisbane, Melbourne
2026-07-05
Recruiting
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
NCT07660055Breast Cancer, Non-small Cell Lung Cancer (NSCLC), Gastric/Gastroesophageal Junction (GEJ) Cancer, Bladder Cancer
Novartis Pharmaceuticals
Phase 1
156
Darlinghurst
2026-06-16
Recruiting
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
NCT07564401Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Novartis Pharmaceuticals
Phase 1/2
80
Clayton
2026-06-16
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Kogarah, Westmead, Melbourne
2026-06-03
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Novartis Pharmaceuticals
Phase 3
460
Adelaide, Clayton
2026-05-27
Recruiting
Novartis Pharmaceuticals
Phase 1
208
Melbourne
2026-05-25
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Camperdown, Liverpool, Chemside, Woolloongabba, Clayton, Perth
2026-05-11
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
NCT07354074Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Novartis Pharmaceuticals
Phase 2
50
Brisbane, North Adelaide
2026-04-28
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Westmead, Caulfield South
2026-03-24
Recruiting
Novartis Pharmaceuticals
Phase 2
272
Albury, Parramatta, Strathfield, East Melbourne
2026-03-09
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Sydney, Waitara, Melbourne
2026-03-09
Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
NCT07226986PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals
Phase 1/2
123
Malvern, Melbourne, Murdoch
2025-12-05
Recruiting
Novartis Pharmaceuticals
Phase 3
31
Brisbane, Nedlands
2025-11-27
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Kogarah, New Lambton Heights, Westmead, Clayton, Heidelberg, Murdoch, Southport
2025-11-11
Recruiting
Novartis Pharmaceuticals
Phase 1/2
188
St Leonards, Melbourne, Liverpool
2025-10-15
Recruiting
Novartis Pharmaceuticals
Phase 2
140
Sydney, North Adelaide
2025-10-09
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Garran, Clayton
2025-10-03
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Camperdown, Kogarah, Box Hill, Heidelberg, Nedlands
2025-08-07
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
NCT06858319Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis
Novartis Pharmaceuticals
Phase 3
220
Gosford, Kogarah
2025-07-28
Active, closed
Novartis Pharmaceuticals
Phase 2
168
Adelaide, Clayton
2025-07-07
Active, closed
Novartis Pharmaceuticals
Phase 2
138
Darlinghurst, Adelaide, Melbourne
2025-07-03
Recruiting
Novartis Pharmaceuticals
Phase 3
940
Darlinghurst, Adelaide, Malvern, Murdoch
2025-07-01
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Melbourne, Parkville, Liverpool, St Leonards
2025-06-23
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
Novartis Pharmaceuticals
Phase 1/2
280
Clayton, Melbourne
2025-04-03
Active, closed
Novartis Pharmaceuticals
Phase 1/2
28
Darlinghurst, Melbourne
2025-02-24
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Fitzroy
2025-02-07
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Phillip, Sydney, Westmead, Melbourne, Parkville
2025-01-31
Active, closed
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
NCT06665256Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals
Phase 2
21
Melbourne
2024-12-17
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Camperdown, Darlinghurst
2024-10-29
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Camperdown, Darlinghurst, New Lambton Heights, Adelaide
2024-10-24
Active, closed
Novartis Pharmaceuticals
Phase 2
251
North Ryde, Herston, Caulfield South, Southport
2024-10-17
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Clayton
2024-09-04
Active, closed
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
Novartis Pharmaceuticals
Phase 2
84
Concord, Clayton
2024-08-05
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Camperdown
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Parramatta, Heidelberg Heights
2024-06-28
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Maroochydore
2024-05-21
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Darlinghurst, Herston, Adelaide, Malvern
2024-03-12
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Gateshead, Tiwi, Clayton, East Melbourne
2024-02-28
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Greenslopes, Carlton, Melbourne
2023-12-07
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Sydney, Brisbane
2023-11-24
Active, closed
Novartis Pharmaceuticals
Phase 1
33
Darlinghurst
2023-11-07
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Maroochydore, Woodville South, Hobart
2023-10-27
Active, closed
Novartis Pharmaceuticals
Phase 3
109
Camperdown, Clayton, Melbourne, Nedlands
2023-10-02
Active, closed
Novartis Pharmaceuticals
Phase 2
144
Clayton, Westmead
2023-08-25
Active, closed
Novartis Pharmaceuticals
Phase 2
41
Garran, Melbourne
2023-08-16
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Gosford, Kogarah, Liverpool, Penrith, St Leonards, Cairns North, Box Hill, St Albans
2023-07-06
Active, closed
Novartis Pharmaceuticals
Phase 3
288
Maroochydore, St Leonards
2023-04-21
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
Garran, Camperdown, Concord, Auchenflower, Sippy Downs, Woolloongabba, Adelaide, Leabrook
2023-03-09
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Garran, Wooloongabba, Clayton
2023-02-03
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Garran, Melbourne
2022-12-30
Active, closed
Novartis Pharmaceuticals
Phase 3
20
Sydney
2022-12-19
Active, closed
Novartis Pharmaceuticals
Phase 3
696
East Melbourne, Parkville
2022-12-09
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Maroochydore, Woodville South, Hobart
2022-08-04
Active, closed
Novartis Pharmaceuticals
Phase 1/2
66
Westmead, Melbourne
2022-07-04
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Botany, New Lambton Heights, Auchenflower, Milton, Woolloongabba, Adelaide, Bedford Park, Leabrook
2021-11-23
Active, closed
Novartis Pharmaceuticals
Phase 1
137
Melbourne
2021-10-21
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals
Phase 3
405
Kingswood, Port Macquarie, Adelaide, Southport
2021-10-06
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Parkville
2021-10-05
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Woolloongabba, Adelaide, Parkville
2021-09-20
Recruiting
Novartis Pharmaceuticals
Phase 1/2
222
Adelaide, Melbourne, Murdoch
2021-07-30
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
Novartis Pharmaceuticals
Phase 3
430
Brisbane, Adelaide, Clayton, Frankston, Buderim, Nedlands
2021-04-09
Active, closed
Atrasentan in Patients With Proteinuric Glomerular Diseases
NCT04573920IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease
Novartis Pharmaceuticals
Phase 2
103
Gosford, Herston, Clayton, Reservoir, St Albans, St Leonards
2021-03-15
Active, closed
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
NCT04699188KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung
Novartis Pharmaceuticals
Phase 1/2
344
Melbourne
2021-02-24
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
404
St Leonards, Reservoir, Saint Albans, Box Hill, Brisbane, Clayton, Gosford, Kingswood
2020-12-11
Active, closed
Novartis Pharmaceuticals
Phase 2
134
North Sydney, Wooloongabba, Subiaco
2020-10-30
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
Novartis Pharmaceuticals
Phase 4
163
Darlinghurst, Parkville
2019-11-04
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Phase 1/2
218
Melbourne
2019-06-26
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
New Lambton Heights, Liverpool, St Leonards
2018-12-28
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Campbelltown, Coffs Harbour, Darlinghurst, Kingswood, Kogarah, North Ryde, St Leonards, Wahroonga
2018-12-07
Active, closed
Novartis Pharmaceuticals
Phase 4
233
Melbourne, Auckland
2015-12-11
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Camperdown, Melbourne, Parkville, Murdoch, Herston
2015-11-02
Active, closed
Novartis Pharmaceuticals
Phase 1
57
Heidelberg
2015-05-27
Active, closed
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
NCT02381886Advanced Malignancies That Harbor IDHR132 Mutations
Novartis Pharmaceuticals
Phase 1
166
Melbourne, Parkville
2015-03-06
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
Novartis Pharmaceuticals
Phase 4
279
Darlinghurst, Herston, Wooloongabba, Bedford Park, Box Hill, Clayton, Franston, Perth
2015-03-05
Active, closed
Novartis Pharmaceuticals
Phase 1/2
259
Westmead, Parkville, Nedlands
2013-10-22
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Parkville
2013-07-26
Rows per page Showing 1–89 of 89
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-australia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,378 studies in total at the last sync on 14 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 89 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Australia?

35 of the 89 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 54 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 89 studies
PhaseStudiesRecruitingShare
Phase 3421547.2%
Phase 220722.5%
Phase 1/215816.9%
Phase 1737.9%
Phase 4303.4%
Phase 2/3222.2%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals8935

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Relapsing Multiple Sclerosis (3) IgA Nephropathy (3) Prostate Cancer (3) Breast Cancer (3) Immunoglobulin A Nephropathy (2) Acute Lymphoblastic Leukemia (2) Primary Myelofibrosis (2) Early Breast Cancer (2) Hidradenitis Suppurativa (2) Systemic Lupus Erythematosus (2) Generalized Myasthenia Gravis (2) Coronary Artery Disease (2) Huntington Disease (2) Primary Immune Thrombocytopenia (ITP) (2) ALK-positive NSCLC (1)
→

Browse trials by site location

Melbourne (29) Clayton (18) Darlinghurst (15) Adelaide (13) Parkville (11) Sydney (9) Camperdown (9) St Leonards (8) Nedlands (7) Westmead (7) Kogarah (6) Herston (6) Brisbane (6) Maroochydore (5) Liverpool (5)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.